FDA Breast Density Reporting Rule is a Critical Step for Women says Volpara Health, the Leader in AI-assisted Breast Density Measurement

Volpara software is used to assess the breast density of more than 6 million US patients annually LYNNWOOD, Wash., March 10, 2023 /PRNewswire/ — Volpara Health Technologies (“Volpara,” “the Group,” or “the Company”; ASX:VHT), a global leader in software for the early detection of breast…